Skip to main content
. Author manuscript; available in PMC: 2025 May 1.
Published in final edited form as: Am J Perinatol. 2023 Apr 18;41(Suppl 1):e1521–e1530. doi: 10.1055/s-0043-1768232

Table 3.

Linear and logistic regression of select pregnancy outcomes by number of medical comorbidities (chronic hypertension, pregestational diabetes, systemic lupus erythematosus, and chronic kidney disease)

No comorbidities (n = 167) 1 comorbidity (n = 151) ≥2 comorbidities (n = 19)
Pregnancy outcomes
% of EM achieveda Referent 5.3 (−2.1 to 12.9) −2.9 (−18.0 to 12.2)
EGA at delivery (wk)a Referent 0.7 (−0.003 to 1.4) −0.5 (−1.9 to 0.9)
Duration of EM (d)a Referent 4.0 (−1.5 to 9.5) 1.1 (−10.0 to 12.2)
Maternal compositeb Referent 0.5 (0.3–0.8) 3.0 (1.1–8.2)
Cesarean deliveryb Referent 1.8 (1.1–3.0) 7.1 (1.5–32.4)
Length of maternal postpartum hospitalization (d)a Referent 0.2 (−0.2 to 0.6) 2.2 (1.3–3.0)
Neonatal compositeb Referent 0.7 (0.4–1.2) 0.7 (0.2–1.8)
Neonatal birth weighta Referent 169 (39–300) −124 (−384 to 135)

Abbreviations: EGA, estimated gestational age; EM, expectant management.

Note: Referent = no comorbidities.

a

Beta coefficients with 95% confidence interval (CI), adjusted for maternal age, BMI, and race.

b

Adjusted odds ratios with 95% CI, adjusted for maternal age, BMI, and race.